abrilumab 0
afasevikumab 0
alacizumab_pegol 0
ascrinvacumab 0
domagrozumab 0
eptinezumab 0
farletuzumab 0
ibritumomab 0
iratumumab 0
itolizumab 0
landogrozumab 0
nesvacumab 0
orticumab 0
radretumab 0
sarilumab 0
tavolixizumab 0
tositumomab 0
